Source: American Heart Journal. Unidade: FMRP
Subjects: DESFIBRILADORES, MORTE SÚBITA CARDÍACA, DOENÇA DE CHAGAS, CIRURGIA TORÁCICA, PRÓTESES E IMPLANTES, DISPOSITIVO DE ASSISTÊNCIA CIRCULATÓRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINELLI, Martino et al. CHronic use of amiodarone aGAinSt implantable cardioverter-defibrillator therapy for primary prevention of death in patients with Chagas cardiomyopathy study: rationale and design of a randomized clinical trial. American Heart Journal, v. 166, n. 6, p. 976-982, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.ahj.2013.08.027. Acesso em: 02 nov. 2025.APA
Martinelli, M., Rassi Júnior, A., Marin Neto , J. A., Paola, A. A. V. de, Berwanger, O., Scanavacca, M. I., et al. (2013). CHronic use of amiodarone aGAinSt implantable cardioverter-defibrillator therapy for primary prevention of death in patients with Chagas cardiomyopathy study: rationale and design of a randomized clinical trial. American Heart Journal, 166( 6), 976-982. doi:10.1016/j.ahj.2013.08.027NLM
Martinelli M, Rassi Júnior A, Marin Neto JA, Paola AAV de, Berwanger O, Scanavacca MI, Kali R, Siqueira SF de. CHronic use of amiodarone aGAinSt implantable cardioverter-defibrillator therapy for primary prevention of death in patients with Chagas cardiomyopathy study: rationale and design of a randomized clinical trial [Internet]. American Heart Journal. 2013 ; 166( 6): 976-982.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2013.08.027Vancouver
Martinelli M, Rassi Júnior A, Marin Neto JA, Paola AAV de, Berwanger O, Scanavacca MI, Kali R, Siqueira SF de. CHronic use of amiodarone aGAinSt implantable cardioverter-defibrillator therapy for primary prevention of death in patients with Chagas cardiomyopathy study: rationale and design of a randomized clinical trial [Internet]. American Heart Journal. 2013 ; 166( 6): 976-982.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2013.08.027
